A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.

A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI

NCT00483028 ·Status: COMPLETED ·Phase: NA

A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease

NCT00455000 ·Status: COMPLETED ·Phase: PHASE1

A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD)

NCT05551741 ·Status: COMPLETED ·Phase: PHASE1

Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease

NCT03056729 ·Status: COMPLETED ·Phase: PHASE1

Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease

NCT01397539 ·Status: COMPLETED ·Phase: PHASE1

A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)

NCT02262975 ·Status: COMPLETED

A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients

NCT01795339 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease

NCT00459550 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease

NCT00555204 ·Status: TERMINATED ·Phase: PHASE2

Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease

NCT03283059 ·Status: UNKNOWN ·Phase: PHASE3

Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects

NCT05363293 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease

NCT03197740 ·Status: COMPLETED ·Phase: PHASE3

Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy Volunteers

NCT04570644 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD

NCT04931459 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil

NCT01406145 ·Status: COMPLETED ·Phase: PHASE1

An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia

NCT01245530 ·Status: COMPLETED ·Phase: PHASE3

Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Donepezil From Single Dose of GB-5001 IM Depot and Aricept® Oral Tablets in Healthy Male Volunteers

NCT05525780 ·Status: COMPLETED ·Phase: PHASE1

Non-Interventional Study With Aricept® Evess

NCT00889603 ·Status: COMPLETED

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Oral ASN51 in Healthy Subjects and Subjects With Alzheimer's Disease

NCT04759365 ·Status: TERMINATED ·Phase: PHASE1

Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects

NCT06304883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Randomized, Double-blind, Placebo-controlled, Sequential Ascending, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2212 in Healthy Subjects

NCT01221259 ·Status: COMPLETED ·Phase: PHASE1

Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers

NCT00777361 ·Status: TERMINATED ·Phase: PHASE1

Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease

NCT00096473 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease

NCT02907567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia

NCT01327859 ·Status: COMPLETED ·Phase: PHASE3